semaglutide 0.75 Weight Loss Drug Wegovy FDA-Approved for Lowering Heart Disease Risk such as high blood pressure Semaglutide for Weight Loss: How

Drop one tablet in water twice daily before meals

If MHRA approval is granted (potentially 2027-2028 based on typical timelines), NHS availability would then require a separate NICE technology appraisal a process that typically takes a further 12 to 18 months

Both medications achieve clinically significant weight reduction, but tirzepatide demonstrates greater efficacy with 15-22% weight loss versus Qsymia's 6-10% in head-to-head comparisons

The primary evidence-based interventions remain: Weight loss through caloric restriction and increased physical activity (target 710% body weight reduction) Dietary modification , including reduced sugar and saturated fat intake Management of associated conditions such as diabetes and dyslipidaemia Alcohol : for NAFLD, keep within UK low-risk drinking guidelines (no more than 14 units per week, ideally less or none)

If you suspect your medication may be causing side effects, including hair loss, you can report this through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)